Home » Thermo Fisher's Xpect Flu A&B Assay Achieves FDA Clearance for Novel Avian Influenza A
Thermo Fisher's Xpect Flu A&B Assay Achieves FDA Clearance for Novel Avian Influenza A
Analytical sensitivity data shows Thermo Fisher’s Remel Xpect Flu A&B assay is able to detect cultured avian influenza A virus. Analytical reactivity testing for this novel strain is in line with the FDA reclassification proposal for assessing detection of emerging viruses that could potentially cause a public health emergency.
DeviceSpace
DeviceSpace
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May